Global Next Generation Cancer Diagnostic Market Size study & Forecast, by Technology ( Next-Generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays) by Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), by Function(Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis) and Regional Analysis, 2022-2029
Global Next Generation Cancer Diagnostic Market is valued at approximately USD 7.98 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 12.38% over the forecast period 2022-2029. Cancer diagnostics is a technique that looks for various proteins, biomarkers, and symptoms to identify the presence of malignant tumours in patients. The method of identifying cancer involves the extensive use of specific technologies and diagnostic tools. The Next Generation Cancer Diagnostic market is expanding because of factors such as the increasing incidence of Cancer, the development of cluster chip technology and potential applications of CTC in cancer management.
The rising prevalence of cancer globally is fostering market growth, according to estimates from the International Agency for Research on Cancer (IARC), The estimated increase in the worldwide burden of cancer is to 27.5 million new cases by 2040 from 1.9 million new cases in year 2021. Furthermore, rising FDA approval for product and technological development along with rising demand for preventive medicine & companion diagnostics and rising cancer medicine research and development activities is creating lucrative growth in the market. For instance, in August 2022, using a pilot project to enhance the validation and regulatory review process for cancer diagnostics based on next-generation sequencing, the Medical Device Innovation Consortium (MDIC), a public-private partnership with US Food and Drug Administration is working to advance medical device regulatory science, announced on Monday that it has begun the next phase of the Somatic Reference Samples (SRS) Initiative (NGS). However, the requirement of an expensive laboratory set-up for the implementation of novel tests may halt market growth.
The key regions considered for the Global Next Generation Cancer Diagnostic Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Janssen Global Services, LLC
Novartis AG
F. Hoffmann-La Roche Ltd
Koninklijke Philips N.V.
Abbott Laboratories
GE Healthcare
Thermo Fisher Scientific, Inc
Agilent Technologies (Dako) Inc
Illumina, Inc.
Opko Health, Inc
Recent Developments in the Market:
In February 2022, Becton and Dickinson Corporation (BD) procured Cytogons in order to secure exclusive access to cutting-edge assays licensed from the EuroFlow Consortium and to solidify BD's position as the industry leader in molecular oncology diagnostics.
Global Next Generation Cancer Diagnostic Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology, Application, Cancer Type, Function, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technologyofferings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Next-Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays
By Application:
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
By Cancer Type:
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Others
By Function:
Therapeutic Monitoring
Companion Diagnostics
Prognostics
Cancer Screening
Risk Analysis
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
The rising prevalence of cancer globally is fostering market growth, according to estimates from the International Agency for Research on Cancer (IARC), The estimated increase in the worldwide burden of cancer is to 27.5 million new cases by 2040 from 1.9 million new cases in year 2021. Furthermore, rising FDA approval for product and technological development along with rising demand for preventive medicine & companion diagnostics and rising cancer medicine research and development activities is creating lucrative growth in the market. For instance, in August 2022, using a pilot project to enhance the validation and regulatory review process for cancer diagnostics based on next-generation sequencing, the Medical Device Innovation Consortium (MDIC), a public-private partnership with US Food and Drug Administration is working to advance medical device regulatory science, announced on Monday that it has begun the next phase of the Somatic Reference Samples (SRS) Initiative (NGS). However, the requirement of an expensive laboratory set-up for the implementation of novel tests may halt market growth.
The key regions considered for the Global Next Generation Cancer Diagnostic Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Janssen Global Services, LLC
Novartis AG
F. Hoffmann-La Roche Ltd
Koninklijke Philips N.V.
Abbott Laboratories
GE Healthcare
Thermo Fisher Scientific, Inc
Agilent Technologies (Dako) Inc
Illumina, Inc.
Opko Health, Inc
Recent Developments in the Market:
In February 2022, Becton and Dickinson Corporation (BD) procured Cytogons in order to secure exclusive access to cutting-edge assays licensed from the EuroFlow Consortium and to solidify BD's position as the industry leader in molecular oncology diagnostics.
Global Next Generation Cancer Diagnostic Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology, Application, Cancer Type, Function, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technologyofferings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Next-Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays
By Application:
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
By Cancer Type:
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Others
By Function:
Therapeutic Monitoring
Companion Diagnostics
Prognostics
Cancer Screening
Risk Analysis
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Next Generation Cancer Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Next Generation Cancer Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.2.3. Next Generation Cancer Diagnostics Market, by Application, 2019-2029 (USD Billion)
1.2.4. Next Generation Cancer Diagnostics Market, by Cancer Type, 2019-2029 (USD Billion)
1.2.5. Next Generation Cancer Diagnostics Market, by Function, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET DYNAMICS
3.1. Next Generation Cancer Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of Cancer
3.1.1.2. Development of cluster chip technology and potential applications of CTC in cancer management
3.1.2. Market Challenges
3.1.2.1. Requirement of expensive laboratory set-up for implementation of novel tests
3.1.3. Market Opportunities
3.1.3.1. Rising demand for preventive medicine & companion diagnostics
3.1.3.2. Rising cancer medicine research and development activities
CHAPTER 4. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Global Next Generation Cancer Diagnostics Market by Technology, Performance - Potential Analysis
6.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
6.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
6.4.1. Next-Generation Sequencing
6.4.2. qPCR & Multiplexing
6.4.3. Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
6.4.4. Protein Microarrays
6.4.5. DNA Microarrays
CHAPTER 7. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Next Generation Cancer Diagnostics Market by Application, Performance - Potential Analysis
7.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
7.4.1. Biomarker Development
7.4.2. CTC Analysis
7.4.3. Proteomic Analysis
7.4.4. Epigenetic Analysis
7.4.5. Genetic Analysis
CHAPTER 8. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY CANCER TYPE
8.1. Market Snapshot
8.2. Global Next Generation Cancer Diagnostics Market by Cancer Type, Performance - Potential Analysis
8.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Cancer Type 2019-2029 (USD Billion)
8.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
8.4.1. Lung Cancer
8.4.2. Breast Cancer
8.4.3. Colorectal Cancer
8.4.4. Cervical Cancer
8.4.5. Others
CHAPTER 9. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY FUNCTION
9.1. Market Snapshot
9.2. Global Next Generation Cancer Diagnostics Market by Function, Performance - Potential Analysis
9.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Function 2019-2029 (USD Billion)
9.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
9.4.1. Therapeutic Monitoring
9.4.2. Companion Diagnostics
9.4.3. Prognostics
9.4.4. Cancer Screening
9.4.5. Risk Analysis
CHAPTER 10. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, REGIONAL ANALYSIS
10.1. Next Generation Cancer Diagnostics Market, Regional Market Snapshot
10.2. North America Next Generation Cancer Diagnostics Market
10.2.1. U.S. Next Generation Cancer Diagnostics Market
10.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
10.2.1.2. Application breakdown estimates & forecasts, 2019-2029
10.2.1.3. Cancer Type breakdown estimates & forecasts, 2019-2029
10.2.1.4. Function breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Next Generation Cancer Diagnostics Market
10.3. Europe Next Generation Cancer Diagnostics Market Snapshot
10.3.1. U.K. Next Generation Cancer Diagnostics Market
10.3.2. Germany Next Generation Cancer Diagnostics Market
10.3.3. France Next Generation Cancer Diagnostics Market
10.3.4. Spain Next Generation Cancer Diagnostics Market
10.3.5. Italy Next Generation Cancer Diagnostics Market
10.3.6. Rest of Europe Next Generation Cancer Diagnostics Market
10.4. Asia-Pacific Next Generation Cancer Diagnostics Market Snapshot
10.4.1. China Next Generation Cancer Diagnostics Market
10.4.2. India Next Generation Cancer Diagnostics Market
10.4.3. Japan Next Generation Cancer Diagnostics Market
10.4.4. Australia Next Generation Cancer Diagnostics Market
10.4.5. South Korea Next Generation Cancer Diagnostics Market
10.4.6. Rest of Asia Pacific Next Generation Cancer Diagnostics Market
10.5. Latin America Next Generation Cancer Diagnostics Market Snapshot
10.5.1. Brazil Next Generation Cancer Diagnostics Market
10.5.2. Mexico Next Generation Cancer Diagnostics Market
10.5.3. Rest of Latin America Next Generation Cancer Diagnostics Market
10.6. Rest of The World Next Generation Cancer Diagnostics Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Janssen Global Services, LLC
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Novartis AG
11.2.3. F. Hoffmann-La Roche Ltd
11.2.4. Koninklijke Philips N.V.
11.2.5. Abbott Laboratories
11.2.6. GE Healthcare
11.2.7. Thermo Fisher Scientific, Inc
11.2.8. Agilent Technologies (Dako) Inc.
11.2.9. Illumina, Inc.
11.2.10. Opko Health, Inc
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Next Generation Cancer Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Next Generation Cancer Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.2.3. Next Generation Cancer Diagnostics Market, by Application, 2019-2029 (USD Billion)
1.2.4. Next Generation Cancer Diagnostics Market, by Cancer Type, 2019-2029 (USD Billion)
1.2.5. Next Generation Cancer Diagnostics Market, by Function, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET DYNAMICS
3.1. Next Generation Cancer Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of Cancer
3.1.1.2. Development of cluster chip technology and potential applications of CTC in cancer management
3.1.2. Market Challenges
3.1.2.1. Requirement of expensive laboratory set-up for implementation of novel tests
3.1.3. Market Opportunities
3.1.3.1. Rising demand for preventive medicine & companion diagnostics
3.1.3.2. Rising cancer medicine research and development activities
CHAPTER 4. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Global Next Generation Cancer Diagnostics Market by Technology, Performance - Potential Analysis
6.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
6.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
6.4.1. Next-Generation Sequencing
6.4.2. qPCR & Multiplexing
6.4.3. Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
6.4.4. Protein Microarrays
6.4.5. DNA Microarrays
CHAPTER 7. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Next Generation Cancer Diagnostics Market by Application, Performance - Potential Analysis
7.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
7.4.1. Biomarker Development
7.4.2. CTC Analysis
7.4.3. Proteomic Analysis
7.4.4. Epigenetic Analysis
7.4.5. Genetic Analysis
CHAPTER 8. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY CANCER TYPE
8.1. Market Snapshot
8.2. Global Next Generation Cancer Diagnostics Market by Cancer Type, Performance - Potential Analysis
8.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Cancer Type 2019-2029 (USD Billion)
8.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
8.4.1. Lung Cancer
8.4.2. Breast Cancer
8.4.3. Colorectal Cancer
8.4.4. Cervical Cancer
8.4.5. Others
CHAPTER 9. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY FUNCTION
9.1. Market Snapshot
9.2. Global Next Generation Cancer Diagnostics Market by Function, Performance - Potential Analysis
9.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Function 2019-2029 (USD Billion)
9.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
9.4.1. Therapeutic Monitoring
9.4.2. Companion Diagnostics
9.4.3. Prognostics
9.4.4. Cancer Screening
9.4.5. Risk Analysis
CHAPTER 10. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, REGIONAL ANALYSIS
10.1. Next Generation Cancer Diagnostics Market, Regional Market Snapshot
10.2. North America Next Generation Cancer Diagnostics Market
10.2.1. U.S. Next Generation Cancer Diagnostics Market
10.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
10.2.1.2. Application breakdown estimates & forecasts, 2019-2029
10.2.1.3. Cancer Type breakdown estimates & forecasts, 2019-2029
10.2.1.4. Function breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Next Generation Cancer Diagnostics Market
10.3. Europe Next Generation Cancer Diagnostics Market Snapshot
10.3.1. U.K. Next Generation Cancer Diagnostics Market
10.3.2. Germany Next Generation Cancer Diagnostics Market
10.3.3. France Next Generation Cancer Diagnostics Market
10.3.4. Spain Next Generation Cancer Diagnostics Market
10.3.5. Italy Next Generation Cancer Diagnostics Market
10.3.6. Rest of Europe Next Generation Cancer Diagnostics Market
10.4. Asia-Pacific Next Generation Cancer Diagnostics Market Snapshot
10.4.1. China Next Generation Cancer Diagnostics Market
10.4.2. India Next Generation Cancer Diagnostics Market
10.4.3. Japan Next Generation Cancer Diagnostics Market
10.4.4. Australia Next Generation Cancer Diagnostics Market
10.4.5. South Korea Next Generation Cancer Diagnostics Market
10.4.6. Rest of Asia Pacific Next Generation Cancer Diagnostics Market
10.5. Latin America Next Generation Cancer Diagnostics Market Snapshot
10.5.1. Brazil Next Generation Cancer Diagnostics Market
10.5.2. Mexico Next Generation Cancer Diagnostics Market
10.5.3. Rest of Latin America Next Generation Cancer Diagnostics Market
10.6. Rest of The World Next Generation Cancer Diagnostics Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Janssen Global Services, LLC
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Novartis AG
11.2.3. F. Hoffmann-La Roche Ltd
11.2.4. Koninklijke Philips N.V.
11.2.5. Abbott Laboratories
11.2.6. GE Healthcare
11.2.7. Thermo Fisher Scientific, Inc
11.2.8. Agilent Technologies (Dako) Inc.
11.2.9. Illumina, Inc.
11.2.10. Opko Health, Inc
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Next Generation Cancer Diagnostics Market, report scope
TABLE 2. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 4. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Cancer Type 2019-2029 (USD Billion)
TABLE 6. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Function 2019-2029 (USD Billion)
TABLE 7. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Next Generation Cancer Diagnostics Market
TABLE 72. List of primary sources, used in the study of global Next Generation Cancer Diagnostics Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Next Generation Cancer Diagnostics Market, report scope
TABLE 2. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 4. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Cancer Type 2019-2029 (USD Billion)
TABLE 6. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Function 2019-2029 (USD Billion)
TABLE 7. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Next Generation Cancer Diagnostics Market
TABLE 72. List of primary sources, used in the study of global Next Generation Cancer Diagnostics Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Next Generation Cancer Diagnostics Market, research methodology
FIG 2. Global Next Generation Cancer Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Next Generation Cancer Diagnostics Market, key trends 2021
FIG 5. Global Next Generation Cancer Diagnostics Market, growth prospects 2022-2029
FIG 6. Global Next Generation Cancer Diagnostics Market, porters 5 force model
FIG 7. Global Next Generation Cancer Diagnostics Market, pest analysis
FIG 8. Global Next Generation Cancer Diagnostics Market, value chain analysis
FIG 9. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Next Generation Cancer Diagnostics Market, regional snapshot 2019 & 2029
FIG 15. North America Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
FIG 19. Global Next Generation Cancer Diagnostics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Next Generation Cancer Diagnostics Market, research methodology
FIG 2. Global Next Generation Cancer Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Next Generation Cancer Diagnostics Market, key trends 2021
FIG 5. Global Next Generation Cancer Diagnostics Market, growth prospects 2022-2029
FIG 6. Global Next Generation Cancer Diagnostics Market, porters 5 force model
FIG 7. Global Next Generation Cancer Diagnostics Market, pest analysis
FIG 8. Global Next Generation Cancer Diagnostics Market, value chain analysis
FIG 9. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Next Generation Cancer Diagnostics Market, regional snapshot 2019 & 2029
FIG 15. North America Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
FIG 19. Global Next Generation Cancer Diagnostics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
